Toggle navigation
ABOUT US
Overview
Leadership
Governance
Board
Our purpose
Global footprint
Our global reach
Partners
Press releases
News
Our science
Drug optimization
Lauriad
®
technology
Overview
How it works
Scientific publications
Lauriad
®
applications
OUR MEDICINES
PIPELINE
Commercialized medicines
Sitavig
®
Loramyc
®
PARTNER WITH US
Commercial & Industrial partners
Academic & Research collaborations
Careers
Working at Vectans Pharma
Join us
CONTACT
Nomination of François Boutignon as Chief Innovation and Technology Officer
Read the press release
Last news
Exclusive agreement with the Menarini group and Berlin Chemie for Sitavig®
Exclusive agreement with the Menarini group and Berlin Chemie
Season's greetings
Vectans Pharma participated in a symposium about new treatments in Oropharyngeal Candidiasis
CPhI Worldwide 2022 in Frankfurt, November 1
st
-3
rd
230 Bureaux de la colline
92213 Saint-Cloud
France
contact@vectans.com
FOLLOW US
Copyright © VECTANS PHARMA
Legal notices and privacy policy
